Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...
Taking anti-inflammatory drugs after surgery is fairly standard protocol. But a new study from researchers at Michigan State ...
A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...
Cambridge researchers have discovered that an existing therapy which boosts protective immune cells in people who recently ...
A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...
Investing.com -- InflaRx N.V. (NASDAQ:IFRX) stock dropped 2.5% Thursday after the biopharmaceutical company announced a ...
Part of the challenge lies with identifying otherwise healthy individuals — especially women — who lack standard modifiable ...
InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...
Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...
Global health body says it is sifting the wheat from the chaff in order to save lives – but critics fear it is pandering to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback